A Clinical Consensus Guideline for Hemodynamic Management of Infants with Congenital Diaphragmatic Hernia: A Delphi Study

Every newborn arrives with a set of instructions written in their own biology, a blueprint for how their heart and lungs should work together. For most, this system begins to function smoothly the moment they take their first breath. But for some, the blueprint is flawed from the start. One such condition is a congenital diaphragmatic hernia, a birth defect where a hole in the muscle that separates the chest from the abdomen allows the stomach and intestines to push up into the chest cavity. This intrusion crowds the developing lungs, preventing them from growing to their full size and causing the blood vessels inside them to become stiff and narrow. The result is a struggle to get oxygen into the blood, a condition known as pulmonary hypertension.

For decades, doctors have understood that the lungs are the primary problem in these infants. However, a growing body of research has revealed that the heart is often caught in the crossfire, sometimes even failing as a direct result of the pressure in the lungs. The heart is a dual pump, with one side sending blood to the lungs and the other sending it to the rest of the body. When the lungs are stiff, the right side of the heart has to work much harder to push blood through, which can cause it to weaken. In some cases, the left side of the heart, which is responsible for pumping blood to the body, may also be underdeveloped or weakened by the same pressure changes. Because these infants can deteriorate rapidly, doctors need a clear way to figure out exactly which part of the heart is struggling and why, so they can choose the right medicine to help. Without this clarity, treatments meant to help one part of the system might accidentally hurt another.

A team of experts from hospitals across the United States and Canada recently came together to solve this puzzle. They recognized that while many doctors were treating these infants, there was no single, agreed-upon rulebook for how to manage the complex blood flow issues that arise. Practices varied wildly from one hospital to another, often depending on the personal experience of the local team rather than a shared standard. To fix this, the group, known as the Children's Hospitals Neonatal Consortium, launched a rigorous project to create a unified set of guidelines. They did not simply vote on what felt right; they built their recommendations on a foundation of existing scientific evidence, a national survey of current practices, and a structured process of expert agreement designed to filter out bias and uncertainty.

The researchers began by gathering every relevant study published over the last two decades, narrowing a list of hundreds of papers down to the most reliable ones. They found that while there was a lot of information about the lungs, the data on how to manage the heart was often small, scattered, or based on single hospitals. To fill these gaps, they looked at what doctors were actually doing in real-world settings across the country. They then brought together a diverse group of specialists, including neonatologists, surgeons, and cardiologists, to review this information. Using a method called the Delphi process, the group went through three rounds of anonymous voting and discussion. In each round, they refined their ideas until they reached a strong consensus on what should be done. This process allowed them to separate what was known from what was merely a guess, creating a guide that balances hard evidence with the collective wisdom of the field.

The resulting guidelines offer a new way of thinking about these infants, moving away from a one-size-fits-all approach toward a strategy that matches treatment to the specific type of heart problem the baby is facing. The experts identified three main patterns, or phenotypes, that these infants can fall into. The first is a situation where the lungs are stiff, causing the right side of the heart to struggle while the left side remains strong. The second is the opposite: the left side of the heart is weak, which backs up pressure into the lungs. The third is a mix of both. The guidelines emphasize that these conditions are not static; a baby can shift from one pattern to another as they grow or as their condition changes. Therefore, the first step in care is to get a detailed picture of the heart's structure and function within the first day of life using an ultrasound, a non-invasive imaging technique. This initial scan, reviewed by a heart specialist, helps determine if there are other heart defects and establishes a baseline for how the heart is pumping.

Once the baseline is set, the guidelines provide specific instructions on how to monitor the infant and choose medications. The team agreed that doctors should look at a wide range of signs, not just blood pressure. They should check how well the kidneys are working, the level of acid in the blood, and the direction of blood flow through the small openings that are normal in newborns but can become problematic in these cases. This comprehensive view helps doctors understand if the heart is getting enough oxygen and if the blood is flowing to the body effectively.

When it comes to medication, the guidelines offer crucial warnings and suggestions based on the specific heart pattern. For instance, a common drug used to raise blood pressure in newborns, dopamine, was found to potentially make the lung problems worse by tightening the blood vessels in the lungs. The experts now recommend using this drug with extreme caution. Instead, they suggest that for infants whose right heart is failing but whose left heart is working well, a drug called vasopressin might be a better choice because it can help the heart without tightening the lung vessels as much. If the left heart is the one struggling, a different type of medicine called epinephrine is recommended to help it pump harder, though doctors must watch closely for side effects like a racing heart or constriction of blood vessels. The guidelines also note that keeping a small fetal blood vessel, called the ductus arteriosus, open with a drug called prostaglandin E1 can sometimes act as a safety valve, allowing the heart to relieve pressure when it is under too much stress.

The authors are careful to note that these guidelines are not a magic cure, nor do they replace the judgment of a skilled doctor. They represent the best possible consensus given the current state of knowledge, which is still limited by the rarity of the condition and the difficulty of running large-scale clinical trials on such fragile infants. Many of the recommendations are based on expert agreement and smaller studies rather than definitive proof, meaning the medical community must remain open to new discoveries. However, by providing a shared framework for assessment and treatment, these guidelines aim to reduce the confusion that currently exists between different hospitals. They offer a path toward more consistent, physiology-based care, ensuring that every infant with this condition receives a treatment plan tailored to the unique mechanics of their own heart and lungs. The ultimate goal is to stabilize these babies long enough for their bodies to heal, improving their chances of survival and recovery.